COMMUNIQUÉS West-GlobeNewswire

Sienna Announces First Quarter 2024 Results Release Date and Conference Call
02/04/2024
MARKHAM, Ontario, April 02, 2024 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (“ Sienna ” or the “ Company ”) (TSX: SIA) announced that it will report its 2024 first quarter results after market close on Thursday, May [...]
OWN.CANCER campaign announces $250K+ donation match to help make new Arthur J.E. Child Comprehensive Cancer Centre among world’s best
02/04/2024
The City of Calgary to recognize April 18-24, 2024, as OWN.CANCER week; local organizations to support OWN.CANCER campaign through individual initiatives CALGARY, Alberta, April 02, 2024 (GLOBE NEWSWIRE) -- Today, the [...]
Cayaba Care Welcomes Adaeze Enekwechi As New CEO
02/04/2024
Former Obama White House official brings deep public and private healthcare experience to drive culturally-informed maternal care PHILADELPHIA, April 02, 2024 (GLOBE NEWSWIRE) -- Cayaba Care, a value-based, maternal [...]
Capsa Healthcare Unveils Enhanced KL1Plus Pharmacy Automation with New Aura Platform
02/04/2024
COLUMBUS, Ohio, April 02, 2024 (GLOBE NEWSWIRE) -- Capsa Healthcare, a global leader in advanced healthcare workflow solutions, announces the enhanced KL1Plus pharmacy prescription filling device, now powered by Capsa’s [...]
ADARx Pharmaceuticals Appoints Dr. Chris Storgard as Chief Medical Officer
02/04/2024
– Seasoned medical leader becomes ADARx's CMO to lead advancement of multiple clinical development programs – SAN DIEGO, April 02, 2024 (GLOBE NEWSWIRE) -- ADARx Pharmaceuticals, Inc. (ADARx), a clinical stage [...]
Viemed Announces Acquisition of Majority Interest in HomeMed, Forging Partnership With East Alabama Health
02/04/2024
LAFAYETTE, La., April 02, 2024 (GLOBE NEWSWIRE) -- Viemed Healthcare, Inc. (the “Company” or “Viemed”) (NASDAQ:VMD), a national leader in respiratory care and technology-enabled home medical equipment services, [...]
Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs
02/04/2024
CARLSBAD, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. (“NAI”) (Nasdaq: NAII) today announced the expected May 2024 reopening of its state-of-the-art high-volume powder blending [...]
Luna Named Among 2024's Most Innovative Healthcare Companies by Fast Company
02/04/2024
NASHVILLE, Tenn., April 02, 2024 (GLOBE NEWSWIRE) -- Luna , the leading provider of in-home, in-person physical therapy (PT), is proud to announce its ranking on Fast Company’s annual list of the World’s Most Innovative [...]
Cannabix Technologies Welcomes Dr. Phillip Olla to the Board of Directors
02/04/2024
VANCOUVER, British Columbia, April 02, 2024 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana and alcohol breath testing devices is pleased to [...]
NurExone Reports Fourth Quarter and Year Ended December 31, 2023 Financial Results and Provides Company Update
02/04/2024
TORONTO and HAIFA, Israel, April 02, 2024 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (Germany: J90) (the “Company” or “NurExone”), a pioneering biopharmaceutical company, developing regenerative medicine [...]
Inozyme Pharma to Participate at the 23rd Annual Needham Virtual Healthcare Conference
02/04/2024
BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Inozyme Pharma, Inc. (Nasdaq: INZY) (“the Company” or “Inozyme”), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of [...]
GLUCOTRACK ANNOUNCES INCREASED SENSOR LONGEVITY FOR ITS IMPLANTABLE CONTINUOUS BLOOD GLUCOSE MONITOR
02/04/2024
Computational modeling with The Technology Partnership shows sensor longevity beyond 3 years; 1 year longer than previously announced Implantable Continuous Blood Glucose Monitor technology could transform lives of [...]
Cerevance to Participate at the 23rd Annual Needham Virtual Health Care Conference
02/04/2024
BOSTON, April 02, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, today announced participation at the upcoming 23 rd Annual [...]
Adial Pharmaceuticals Reports 2023 Fiscal Year Financial Results and Provides Business Update
02/04/2024
Received Favorable Feedback from US and EU Regulatory Agencies Advancing Discussions with Potential Strategic Partners Received $4.3 Million in Gross Proceeds from Warrant Exercises Subsequent to Year-End 2023 GLEN [...]
Nexalin Technology Announces the Appointment of Government Affairs Veteran William A. Hudson, Jr. to Military & Government Advisory Board
02/04/2024
Previously served as Acting General Counsel to the Department of Veterans Affairs HOUSTON, TEXAS, April 02, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (the “Company” or “Nexalin”) (Nasdaq: NXL; NXLIW), today [...]
Telomir Pharmaceuticals’ Anti-Aging Expert and NYT Bestselling Author Michael F. Roizen, MD, to Present Promising Pre-Clinical Data for Age-Reversal Drug Telomir-1 at the National Press Club in Washington, DC, on April 15, 2024
02/04/2024
Telomir’s pre-clinical studies demonstrate its lead development product, Telomir-1, elongates telomere caps on human normal embryonic fibroblast cells by stimulating the enzyme telomerase New York Times article supports [...]
Vaccinex Reports 2023 Financial Results and Provides Corporate Update
02/04/2024
Expect Topline Data for Phase 1/2a Randomized SIGNAL-AD Study of Pepinemab for Alzheimer’s Disease in Q3 2024 Company raised $17.9 million of new financing during Q4 2023 and Q1 2024 ROCHESTER, N.Y., April 02, 2024 ( [...]
BioCorRx Reports Business Update for 2023
02/04/2024
ANAHEIM, CA, April 02, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire — BioCorRx Inc. (OTCQB: BICX) (the “Company”) , a developer and provider of innovative treatment programs for substance abuse and related disorders, today [...]
MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines (BCMs)
02/04/2024
Be Biopharma to use MaxCyte’s Flow Electroporation® technology and ExPERT™ platform within its Engineered B Cell Medicines programs ROCKVILLE, Md., April 02, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc. , (Nasdaq: MXCT; LSE: [...]

Pages